Capital Markets
Deals, listings and the cost of money
IPOs, mergers, buybacks and credit issuance — what the terms of a deal say about what this market is willing to fund right now.
2026-10-21
%22%2F%3E%0A%20%20%3Ccircle%20cx%3D%22220%22%20cy%3D%22150%22%20r%3D%22180%22%20fill%3D%22%2322d3ee%22%20fill-opacity%3D%220.12%22%2F%3E%0A%20%20%3Ccircle%20cx%3D%221010%22%20cy%3D%22130%22%20r%3D%22220%22%20fill%3D%22%2338bdf8%22%20fill-opacity%3D%220.08%22%2F%3E%0A%20%20%3Ccircle%20cx%3D%22920%22%20cy%3D%22520%22%20r%3D%22170%22%20fill%3D%22%2322d3ee%22%20fill-opacity%3D%220.06%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M140%20430h920%22%20stroke%3D%22url(%23line)%22%20stroke-width%3D%2212%22%20stroke-linecap%3D%22round%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M220%20360c120-150%20260-220%20380-220s260%2070%20380%20220%22%20fill%3D%22none%22%20stroke%3D%22%2367e8f9%22%20stroke-opacity%3D%220.5%22%20stroke-width%3D%2216%22%20stroke-linecap%3D%22round%22%20stroke-linejoin%3D%22round%22%2F%3E%0A%20%20%3Cpath%20d%3D%22M300%20398h600%22%20stroke%3D%22%2394a3b8%22%20stroke-opacity%3D%220.24%22%20stroke-width%3D%228%22%20stroke-linecap%3D%22round%22%2F%3E%0A%20%20%3Ctext%20x%3D%22220%22%20y%3D%22510%22%20fill%3D%22%23e2e8f0%22%20fill-opacity%3D%220.7%22%20font-family%3D%22Arial%2C%20Helvetica%2C%20sans-serif%22%20font-size%3D%2238%22%20letter-spacing%3D%228%22%3EINSIGHTS%3C%2Ftext%3E%0A%3C%2Fsvg%3E)
General Motors's $20 Billion Buyback Is a Credit Decision, Not a Growth One — the Stock Fell 8.6% in Two Days
General Motors beat third-quarter numbers — adjusted diluted EPS of $3.70 against $3.63 expected, revenue of $50.0 billion — then authorized a $20.0 billion multi-year repurchase equal to roughly 31% of its market cap. The stock fell 6.8% on Oct. 20 and another 1.9% on Oct. 21, an 8.6% two-session decline, because the narrowed full-year adjusted EPS range of $12.75–$13.75 landed below consensus while the commodity, logistics and DRAM cost headwind was raised to about $2 billion and 2027 profit was made explicitly conditional on commodity prices moderating. The cash behind the authorization is the cash freed by the EV exit — $7.4 billion of charges, $4.6 billion already paid — plus the $250 million quarterly dividend from a captive finance book carrying $113.0 billion of debt at 5.5% with delinquencies and charge-offs all rising. At a 5.11% long end, shrinking the share count with that earnings mix is a credit decision rather than a growth one: it fixes the denominator and leaves the numerator exposed to a $4.26 gallon and a Nov. 3 election.
Meta's $900 Billion Class C Is Not a Second AI Security — the Spread, Not the Listing, Prices the Buildout
Meta's board approved a new non-voting Class C share on October 21, 2026, to be distributed one-for-one to every Class A and Class B holder, with Class A trading as a two-for-one split once it lands in January 2027 — so the class raises nothing on day one and changes no shareholder's vote. What it changes is the menu: free cash flow turned negative at -$2.12 billion in the September quarter, buybacks were zero for a second straight quarter, and the 2026 capital spending guide was narrowed up to $135-145 billion, leaving roughly $56 billion more to fund between 2026 and 2027 consensus. The Founder Alignment Agreement staples Mark Zuckerberg's Class C to his Class B and frees only 2.5% a quarter for eight years, which makes the Class C discount to Class A a clean daily quote on the equity cost of the AI buildout — the leg credit markets already priced, with Meta's $27.3 billion Hyperion bond near 91 cents.
Moody's Missed on Earnings and Lost 40% of Its High-Yield Fees: AI Credit Became the Ratings Engine, and the Same Credit Is Already Cracking
Moody's reported third-quarter 2026 adjusted diluted EPS of $4.14 on Oct. 21 against a consensus of $4.25 to $4.31, on revenue of $2.02B that grew just 1% — the first miss in seven consecutive quarters of beats. The cause was composition, not demand: high-yield ratings revenue fell 40% and bank-loan revenue 27% while investment-grade revenue rose 18% on AI-driven issuance, so recurring revenue and analytics ($3.69B ARR, up 8%) now carry a franchise whose fast-growing line is tied to a handful of hyperscaler capex budgets. Guidance was reaffirmed at $16.50 to $17.00, which mathematically leaves the fourth quarter flat year over year at roughly $3.60 of adjusted EPS. For investors the trade is now two-sided: the agency is paid on the AI credit boom, while the same credit is repricing in the market — CoreWeave's bonds yield near 15% with roughly 63% five-year default probability priced in, and large banks carry AI-adjacent commitments equal to about 25% of tier-1 capital.
One Buyer: $1.5 Billion of a Single Day's $2.2 Billion Went to One AI Chip Company as Fintech's Late-Stage Funding Fell 43%
More than $2.2 billion of startup financing was announced worldwide in the 24 hours to Oct 20, 2026, and roughly two-thirds of it — a single $1.5 billion Series E — went to Tenstorrent, the RISC-V AI chip company. That concentration is the same force that cut global fintech venture funding 21.4% year on year in Q3 2026, with rounds of $100 million or more down 43.3% quarter on quarter and accounting for roughly 93% of the dollar decline. With venture's marginal dollar committed to AI infrastructure, fintech's late-stage money must now come from strategic buyers or the IPO market, which makes self-funding public fintechs the likely consolidators and every private fintech that still needs a $100 million round a candidate for the 2027 IPO queue.
2026-10-20
Blackstone's $10 Billion IntraFi Bid Prices an 80%-Margin Network Below S&P Global's Own Multiple
On Oct 20, 2026, Reuters reported that Blackstone and Warburg Pincus have hired Morgan Stanley and Guggenheim Securities to explore a sale of IntraFi at more than $10 billion. On $630 million of annual EBITDA the print implies about 15.9x enterprise value to EBITDA — under the 16.7x trailing multiple at which S&P Global trades and far below Moody's at 22.4x and MSCI at 23.3x, for an asset with roughly double their EBITDA margin. That is not a revived exit market but the one lane still open: global M&A value fell 41% in the third quarter of 2026 to $993 billion, while $10 billion-plus mega-deals grew 114% year over year to $1.3 trillion in the first half and now supply 42% of all deal value. Read IntraFi as the template for what still clears — scaled, contract-like financial infrastructure bought by a strategic that can refinance 9.67% leveraged paper — not as evidence that private credit can lean on exits.
32% Down on Day One: Elice's KOSDAQ Crash Is Now the Tape Every Other AI-Data-Center IPO Has to Beat
Elice, the largest Korean AI data-center listing of 2026, fell as much as 33% on its KOSDAQ debut despite 408x retail oversubscription and a clean H1 P&L — the worst first-day drop in any Korea IPO above US$100M on record. The market isn't doubting AI; it's repricing the multi-trillion-dollar neocloud buildout that Elice sits on top of, and that re-pricing now sits ahead of DayOne's Nasdaq filing, Nscale's $35B target, AirTrunk's delayed Singapore trust and Firmus's scrapped Australian offering. HBM and GPUs (SK Hynix, Samsung Electronics, NVIDIA) still get paid per watt; the leveraged neoclouds that funded the build (CoreWeave) and the debut hopefuls priced at peak multiples are what investors are pulling away from.
Otter.ai's $320M Deal Sets a $30 Per-Seat Price on Standalone Meeting AI — and Bundled Incumbents Can't Match It
Otter.ai closed $320M from General Catalyst's Customer Value Fund on October 20, 2026 — its first large non-equity, revenue-linked facility aimed at doubling enterprise sales. With 35M users, 86% of the Fortune 500 already touching the product, and the deal earmarked to double or triple the sales budget, Otter underwrites a $30 per-seat price tier for standalone meeting AI that Zoom Communications's bundled AI Companion and Microsoft's $30 Copilot must now defend or surrender. The competitive pressure flows through Cisco's Webex, Salesforce's Slack base, and the NVIDIA-backed infrastructure stack underneath.
Anthropic's $2 Trillion IPO Puts Alphabet's $124 Billion Bet on Its Own Rival in the Open
Eric Schmidt's roughly 1% stake in Anthropic, reported on October 19, is the smallest interesting number on a cap table that already contains Alphabet, Nvidia, Amazon and Microsoft. The consequential facts are structural: Alphabet owns about 14% of Anthropic while selling it $200 billion of cloud, guaranteeing its data-center obligations, and competing with Claude — and it has already converted $98.0 billion of that position into reported profit while free cash flow went negative. When Anthropic prices, the prospectus, not the shareholder register, is where that overlap gets disclosed, and public shareholders will own the economics of the arrangement without the vote that could change it.
Tenstorrent Doubles to $6.2B Private, but the $1.5B Round Costs ~6% of One Nvidia Buyback Quarter
Toronto-based Tenstorrent closed a $1.5B Series E at a $6.2B post-money mark on October 19, 2026 — its first hard private valuation event since a $575M up-round in August and the highest profile open-weight AI chip mark of the year. The round, led by Trace Capital and Innovation X with Sandisk and Cadence Ventures on the cap table, is large enough to fund Galaxy server volume manufacturing, but is roughly equal to what NVIDIA Corp returned in stock during six weeks of its $235B buyback. Investors holding Advanced Micro Devices Inc, Broadcom Inc, and the public comp Cerebras Systems Inc now have a defensible read on whether the open-weight inference trade is finally being priced twice — once in private and once at the 2027 IPO window.
Three Bond-Stack Deals in 81 Days: Tradeweb's $1.97B Trumid Bid Confirms the Analytics Layer Clears at Twice the Venue Multiple
Tradeweb agreed on Oct 19, 2026 to buy Trumid for about $1.97B — $1.75B for the business plus roughly $220M of acquired tax assets — targeted to close in the first half of 2027 and accretive to adjusted earnings per share within the first full year after closing. The same month, LSEG confirmed talks to buy Permira's Octus for roughly $3.5B, and in July ICE signed to buy MarketAxess for $167 a share. Read together, the three deals price the same stack in layers: execution venues clear at about 12.6x trailing EBITDA while the credit data and analytics layer is being discussed at roughly 24x. That spread is why venues are paying up for analytics as cash credit fees per million fall — Tradeweb's own cash credit variable fees per million dropped 11.4% year over year in Q2 2026 even as average daily volume rose 18.2%.
2026-10-19
Anthropic Just Pledged 5% to a Public Benefit Fund — and 50.1% of the Vote to Its Founders
On Oct. 18, 2026, Anthropic committed 5% of its shares (subject to stockholder approval) to a new wholly-owned Public Benefit Fund LLC, with an additional 2% added at the board's discretion for every 50% increase in valuation. Combined with founder pledges to donate 80% of their equity and an employee match program covering half the workforce, roughly 20% of Anthropic is now earmarked for the public good. But the same proxy slate asks shareholders to grant the seven co-founders 50.1% voting control via a new Founder LLC — making the headline percentage only half the governance story. With Q3 revenue at $16.8B, an adjusted operating profit, and a Nasdaq listing targeted north of $2T before Thanksgiving, every piece of Anthropic's stack — from Amazon's AWS to Broadcom's TPUs to NVIDIA and SK Hynix's memory — repriced the moment the announcement hit.
Forge Nano Just Put Atomic-Layer Materials on the US Tape. The $199M Trust Walkout Resets the Math.
Archimedes Tech SPAC Partners II shareholders cleared the Forge Nano merger 93.3%–7.2% on Oct 16, sending the atomic-layer deposition specialist public as NANO/NANOW within days. The headline $1.2B pre-money valuation hides a real squeeze: $199M of trust cash was redeemed just before the vote, slashing the planned cash-to-balance-sheet from $417M to closer to $218M, and management is committing that thinner pool to a 3 GWh battery gigafactory that won't produce a cell until 2028. The investment angle isn't the SPAC vote itself — it's the structural pull on Lam Research, Applied Materials, Tokyo Electron, ASM International, and the silicon-anode defense-battery thesis that just got its first pure-play feedstock.
Rare-Earth Recycling Just Got Its First US SPAC — HyProMag's Listing Could Be the Sequel
Three rare-earth and critical-minerals SPACs are racing to a US tape right as China tightens its grip and Washington opens the wallet. Hall Chadwick's REEcycle deal has already signed to claim the first US-listed pure-play rare-earth recycler; Kensington Capital's Nth Cycle follows at a $585M enterprise value; and Mkango's Songwe/Pulawy mining cousin is in registration under the MKAR ticker. HyProMag USA, the recycling vehicle the original brief focused on, is still pre-deal — its announced strategic review points to a late-2026 or early-2027 listing after Texas hub construction milestones, not a wrap on a SPAC today.
Musk's $10.5B SpaceX-to-Every-Kid Pledge Is a Three-Wire Risk: Float, Votes, and the Trump Accounts Lifeline
Elon Musk's Oct 19 promise of one SpaceX share to every U.S. child in 2027 — roughly 73 million shares at the Oct 17 close of $146.03, worth ~$10.5B — tests more than philanthropy. The gift coincides with Anthropic's 5% public-benefit pledge, uses a Trump-administration distribution channel Musk already seeded, and may force Musk's supervoting Class B to convert to Class A on transfer, trimming the ~85% voting block he holds under SpaceX's super-voting charter. For Tesla holders facing a possible merger announcement before December, the real question is whether the pledge is signal, branding, or the first move of a broader Musk wealth-redistribution plan.
TriGemX's $160M PIPE Pits a TRPM8 Pill Against AbbVie's $742M Migraine Franchise — and the Phase 2b Miss Won't Go Away
TriGemX Bio (formerly Kallyope) is taking a Phase 3 TRPM8 migraine drug public through a SPAC merger with TCGX Acquisition Corp, locking in ~$246M of gross proceeds and a ~$600M pro-forma EV under the new TriGemX Bio ticker on Nasdaq. The thesis hinges on elismetrep clearing AbbVie's $742M Q2 2026 migraine franchise with a triptan-resistant mechanism no CGRP inhibitor has touched — but the Phase 2b primary endpoint already missed conventional significance at P=0.0650, and the $160M PIPE runs straight into a mid-2027 readout. The PIPE itself is the real signal: anchored by TCG Crossover Fund III (the SPAC sponsor's own affiliate), with The Column Group and Viking Global Investors repeating from the $94M crossover round — a quality of money that says this is a thesis bet, not a momentum trade.
2026-10-18
Anthropic Told Investors Its Workforce Is 'Less Junior, More Meetings' — the $2T S-1 Has to Clear That Math
Two weeks before its $2T IPO, Anthropic disclosed that its workforce is structurally more senior and is spending ~20% more time in meetings than a year ago. That is the first public admission the S-1's opex-per-head line will keep rising — even as Q3 revenue jumped 45% to $16.8B and adjusted operating margin crossed 11%. The math works only if compute commitments and customer concentration don't tighten; both are visible in the leaked prospectus. Hyperscalers, chip suppliers, and AI-adjacent software are the listed names that absorb the consequences on either side.
Berkshire's $330M Anchor at $33 Frames Bending Sponsors' 5.10% Yield Survival Test
Berkshire's private placement lifts its stake in Bending Sponsors to 4% at $33 a share — a 36% discount to the stock's post-news peak — but the underlying story is a $4.09B-net-debt roll-up that priced its July IPO at $29.00 and now trades near $47 inside a 5.10% 10-year tape. With interest expense up 337% YoY in 2025 and a $1.25B USD term-loan add-on pricing in September, the question is whether Bending Sponsors's AI-rewrite playbook can compound acquired EBITDA faster than its 5.10%-era debt stack.
The AI Trade Can Lose Money Even If the Technology Doesn't — BofA Names the Trigger
Bank of America strategist Sebastian Raedler warned on Oct. 16, 2026 that AI can succeed as a technology while investors in AI stocks still earn poor returns, because forward 12-month hyperscaler capex expectations have roughly tripled to ~$1 trillion — equivalent to ~3% of US GDP — while AI token prices have already fallen ~50% since the summer. The 'even if it works' paradox is now the explicit sell-side trigger into a five-stock earnings gauntlet: Meta on Oct. 21, Microsoft and Alphabet on Oct. 28, AMD on Nov. 3 and Nvidia on Nov. 17.
Burry's 'Supervolcano' Warning Lands on the Worst Nasdaq Week Since June — A Sentiment Tell the Tape Itself Confirms
Michael Burry's Saturday post warning that every market top in the past 40 years sat above a 'caldera of lava' landed one day after the Nasdaq fell2.14% to26,140 — its worst week since June — and CoreWeave bonds traded at 15% yields. The bigger signal is the convergence: AI debt stress at CoreWeave, a 10-year Treasury stuck near 5.10%, a VIX that surged ~21% intraday, and a $1.1 billion bet against NVIDIA and Palantir from a fund manager who has now deregistered his adviser. Burry isn't calling a crash date; he's calling a positioning setup where the surface looks calm while leverage quietly builds underneath.
CoreWeave's 16% Bond Yield Is the Wall the AI Buildout Can't Roll Past
Between Oct. 13 and Oct. 16, CoreWeave's 2031 dollar bond traded above a 15.78% yield to maturity, its 5-year credit default swap broke1,000 basis points, and the stock lost ~25% for the week — the moment Gartner's Oct. 14 prediction that 80% of neoclouds will cease independent operations by 2030 stopped being a forecast and became a credit-spread wall. Nebius and Applied Digital fell 12%+ in sympathy, Goldman Sachs pinned the move on higher-for-longer funding costs for AI-related debt, and the bond market — not the equity tape — is now the leading indicator for the entire sector.
What to expect
Evidence-first notes with a visible point of view.
This section collects sharp takes on earnings, shareholder meetings, and market structure. Each new piece should make the thesis, the facts, and the implications obvious within the first few screens.
Expect direct analysis, not generic commentary.
Expect the data to be explicit and the argument to be easy to follow.